Status:
COMPLETED
European Exposure Study
Lead Sponsor:
Philip Morris Products S.A.
Conditions:
Smoking
Eligibility:
All Genders
21-85 years
Brief Summary
The current study was designed to determine the exposure of adult smokers and non-smokers to cigarette smoke constituents through evaluation of selected biomarkers of exposure.
Detailed Description
The purpose of the study was to provide a greater knowledge about human exposure to cigarette smoke constituents by evaluating selected biomarkers of exposure in smokers and non-smokers. This was an o...
Eligibility Criteria
Inclusion
- Smokers: Subjects who smoked commercial cigarettes exclusively (less than or equal to 10 mg ISO tar yield in Germany and the UK; less than or equal to 12 mg ISO tar yield in Switzerland) with a regular consumption of at least 1 cigarette per day over the last 12 months without change in brand over the previous 3 months.
- or
- Non-smokers: Subjects who did not smoke commercial cigarettes, hand-rolled cigarettes, cigars, pipes, bidis, and did not use other nicotine-containing products (patch, gum, lozenges etc.) within 1 year prior to Visit 1 and throughout the study duration.
Exclusion
- Female subjects with child-bearing potential were to be excluded if
- Subject was pregnant (or did not have negative pregnancy tests) or breast-feeding
- Subject did not agree to use an acceptable method of contraception
Key Trial Info
Start Date :
April 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
1667 Patients enrolled
Trial Details
Trial ID
NCT01237912
Start Date
April 1 2005
End Date
December 1 2006
Last Update
November 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stephen Smith
Belfast, Northern Ireland, United Kingdom, BT96AD